Pharmacological Treatment of Dementia
Identifying Attributes
Care Settings
Country
Publishing Organisation
Type of Quality Indicator
IOM Quality Dimension
Domain
Defining Attributes
Definition
Percentage of patients with dementia or their caregivers with whom available guideline-appropriate pharmacological treatment options and non-pharmacological behaviour and lifestyle modifications were discussed at least once in the last12-month period.
Numerator
Patients with dementia or their caregivers with whom available guideline appropriate pharmacological treatment options and non-pharmacological behaviour and lifestyle modifications were discussed at least once in the last12-month period.
Denominator
All patients with dementia
Exclusions
None
Use of Risk Adjustment
Risk Adjustments
Stratifications
Collection and Reporting Attributes
Type of Data Collection
Data Collection Methods
Frequency of Data Collection
Frequency of Data Collection in Days
Reporting Methods
Reporting Frequency
Reporting Frequency in Days
Indicator Has Recommended Targets
Source and Reference Attributes
Evidence Source
Sanders, A. E., Nininger, J., Absher, J., Bennett, A., Shugarman, S., & Roca, R. (2017). Quality improvement in neurology: Dementia management quality measurement set update. American Journal of Psychiatry, 174(5), 493-498. Schultz, S. K., Llorente, M. D., Sanders, A. E., Tai, W. A., Bennett, A., Shugarman, S., & Roca, R. (2020). Quality improvement in dementia care: Dementia management quality measurement set 2018 implementation update. American Journal of Psychiatry, 177(2), 175-181.
Technical Specifications
Appendix in Sanders, A. E., Nininger, J., Absher, J., Bennett, A., Shugarman, S., & Roca, R. (2017). Quality improvement in neurology: Dementia management quality measurement set update. American Journal of Psychiatry, 174(5), 493-498.